Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ·Healthcare·Biotechnology
$2.19
+4.78%
Mkt Cap $6.34M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$225.00
Range $225.00 – $225.00
Implied Upside
+10174.0%
Consensus $225.00 vs current $2.19